Raymond James Financial
TMCI icon

Raymond James Financial’s Treace Medical Concepts TMCI Stock Holding History

Raymond James Financial’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
331,110
-26,446
-7% -$72.7K ﹤0.01% 3795
2026
Q1 		$479K Buy
357,556
+34,614
+11% +$69K ﹤0.01% 4373
2025
Q4 		$791K Buy
322,942
+288,141
+828% +$1.25M ﹤0.01% 3940
2025
Q3 		$234K Sell
34,801
-13,859
-28% -$90.5K ﹤0.01% 4539
2025
Q2 		$286K Sell
48,660
-26,215
-35% -$171K ﹤0.01% 4315
2025
Q1 		$628K Buy
74,875
+22,133
+42% +$199K ﹤0.01% 3787
2024
Q4 		$392K Buy
+52,742
New +$353K ﹤0.01% 4041

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Raymond James Financial's TMCI Position: Q2 2026 in Review

Raymond James Financial reduced its Treace Medical Concepts (TMCI) stake by 7.4% in Q2 2026, selling an estimated $72.7K and leaving 331,110 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3795.

Raymond James Financial first reported a position in TMCI in Q4 2024 and has held it in 7 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Raymond James Financial held 331,110 shares of Treace Medical Concepts worth $1.32M as of Q2 2026.
  • Raymond James Financial sold 26,446 Treace Medical Concepts shares in Q2 2026, an estimated $72.7K.
  • Treace Medical Concepts made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3795 holding.
  • Raymond James Financial first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 7 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.